China Medical & HealthCare Group Limited announced with effect from 13 May 2021, Mr. Kong has ceased to be an executive director, member of the executive committee, investment committee and the remuneration committee of the company, and will cease to act as an authorised Representative of the Company under Rule 3.05 of the Listing Rules and the Companies Ordinance (Cap. 622 of the Laws of Hong Kong) (the "Companies Ordinance"); Dato' Wong has ceased to be a non-executive director, member of the nomination committee and the remuneration committee of the Company; and Ms. Fung Ching Man, Ada, the company secretary of the Company, has been appointed by the Board as an Authorised Representative of the Company under the Listing Rules and the Companies Ordinance.